Estimation of extended medical examination coverage indexes in young individuals after novel coronavirus infection

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Abstract. The consequences of novel coronavirus infection (COVID-19) are manifesting themselves in individuals, including young people, in the form of persistent complaints in the period ≥ 6 months after the recovery. At the same time, patients with chronic infectious diseases (CNDs) need special attention and timely diagnosis of the post-COVID state to prevent complications. A range of extended medical examination measures is carried out for the early detection of COVID-19 complications.

The aim: to estimaye the coverage rates of extended medical examination of young patients after COVID-19.

Material and methods. A retrospective cross-sectional analysis of 339 medical records of outpatients aged 18 to 44 years who had COVID-19 was performed. Complaints, the presence of concomitant CNDs, and the fact of undergoing a medical examination were assessed.

Results. The analysis included data from 40.4% of male and 59.6% of female patients (median age – 31.7 years). Mild degree of COVID-19 severity had 95.6% of patients, moderate – 4.4%, 98.5% of those studied were treated on an outpatient basis. Among patients with chronic pathologies, 29.5% had one disease, 13.6% had two, and 6.5% had three or more diseases. In the structure of CNDs, the leading ones were chronic autoimmune thyroiditis (6.8%), chronic tonsillitis (6.5%), and arterial hypertension (6.5%). Complaints related to COVID-19 after the recovery were made by 85 patients with CNDs (25.1%), including complaints of weakness (23.5%), dizziness and headache (23.5%), palpitations and chest discomfort (17.6%). Mandatory medical examination was undergone by 45 (13.3%), and expanded medical examination was undergone by 18 persons (5.3%). Among patients with CNDs, similar indexes were 30 (17.9%) and 13 (7.7%) persons, respectively.

Conclusion. Coverage of young individuals who have had COVID-19, including patients with existing CNDs, with preventive measures is not effective enough.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Ekaterina Ushakova

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Хат алмасуға жауапты Автор.
Email: ekaterinakorablyova@yandex.ru
ORCID iD: 0000-0003-3265-9398

MD, postgraduate student, assistant

Ресей, Moscow

Yulia Pakhomova

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Email: upxmva@gmail.com
ORCID iD: 0009-0001-5620-3793

MD

Ресей, Moscow

Olga Kladovikova

Diagnostic Clinical Center No. 1 of the Department of Healthcare of Moscow

Email: kladovikova.olga@gmail.com
ORCID iD: 0000-0001-7977-5850

MD, acting chief physician

Ресей, Moscow

Vera Larina

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Email: larina_vn@rsmu.ru
ORCID iD: 0000-0001-7825-5597

MD, Dr. Sci. (Medicine), professor

Ресей, Moscow

Әдебиет тізімі

  1. Harris E. US Survey: About 7% of adults, 1% of children have had long COVID. JAMA. 2023; 330(16): 1516. https://doi.org/10.1001/jama.2023.19208. PMID: 37792410.
  2. Pazukhina E., Andreeva M., Spiridonova E. et al.; Sechenov StopCOVID Research Team. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022; 20(1): 244. https://doi.org/10.1186/s12916-022-02448-4. PMID: 35794549. PMCID: PMC9257572.
  3. Юбицкая Н.С., Юренко А.В., Косьяненко Н.Г., Минеева Е.Е. Комплексная персонализированная реабилитация пациентов с постковидным синдромом. Тихоокеанский медицинский журнал. 2023; (4): 32–36. [Yubitskaya N.S., Yurenko A.V., Kosyanenko N.G., Mineeva E.E. Сombined rehabilitation after COVID-19 coronavirus infection. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal. 2023; (4): 32–36 (In Russ.)]. https://doi.org/10.34215/1609-1175-2023-4-32-36. EDN: HHIWZW.
  4. Чучалин А.Г., Аметов А.С., Арутюнов Г.П. с соавт. Вопросник для первичной самооценки здоровья пациентов, перенесших новую коронавирусную инфекцию: Рекомендации Междисциплинарного совета экспертов по проведению скрининга симптомов постковидного периода при углубленной диспансеризации. Пульмонология. 2021; 31(5): 599–612. [Chuchalin A.G., Ametov A.S., Arutyunov G.P. et al. Questionnaire for initial self-assessment in post-COVID period: Recommendations of Multidisciplinary expert board on screening of post-COVID syndrome during an expanded medical check-up. Pul’monologiya = Pulmonology. 2021; 31(5): 599–612 (In Russ.)]. https://doi.org/10.18093/0869-0189-2021-31-5-599-612. EDN: RWKPNE.
  5. Николаев Н.А., Драпкина О.М., Ливзан М.А. с соавт. Исследование «МАРКИЗ»: скрининг постковидного синдрома с использованием анкеты выявления симптомов и факторов риска неинфекционных заболеваний. Кардиоваскулярная терапия и профилактика. 2022; 21(12): 190–200. [Nikolaev N.A., Drapkina O.M., Livzan M.A. et al. MARKIZ study: Screening for post-COVID-19 syndrome using a questionnaire to identify symptoms and risk factors for noncommunicable diseases. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2022; 21(12): 190–200 (In Russ.)]. https://doi.org/10.15829/1728-8800-2022-3484. EDN: HUBDME.
  6. Scharf R.E., Anaya J.M. Post-COVID syndrome in adults – an overview. Viruses. 2023; 15(3): 675. https://doi.org/10.3390/v15030675. PMID: 36992384. PMCID: PMC10056158.
  7. Воробьев П.А., Воробьев А.П., Краснова Л.С. Постковидный синдром: образ болезни, концепция патогенеза и классификация. Проблемы стандартизации в здравоохранении. 2021; (5–6): 3–10. [Vorobyov P.A., Vorobyov A.P., Krasnova L.S. Postcovid syndrome: The image of the disease, the concept of pathogenesis and classification. Problemy standartizatsii v zdravookhranenii = Problems of Standardization in Healthcare. 2021; (5–6): 3–10 (In Russ.)]. http://doi.org/10.26347/1607-2502202105-06003-010. EDN: JMLCKZ.
  8. Chen C., Haupert S.R., Zimmermann L. et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J Infect Dis. 2022; 226(9): 1593–607. https://doi.org/10.1093/infdis/jiac136. PMID: 35429399. PMCID: PMC9047189.
  9. Mannan A., Mehedi H.M.H., Chy N.U.H.A. et al. A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: Clinical epidemiology and short-term outcomes in recovered individuals. New Microbes New Infect. 2021; 40: 100838. https://doi.org/10.1016/j.nmni.2021.100838. PMID: 33520252. PMCID: PMC7834423.
  10. Сергеева В.А., Липатова Т.Е. Нарушения сна, сердечно-сосудистые симптомы и динамика массы тела у женщин с постковидным синдромом. Медицинский совет. 2022; 16(14): 193–199. [Sergeeva V.A., Lipatova T.E. Sleep disorders, cardiovascular symptoms and body weight dynamics in women with post-COVID-19 syndrome. Meditsinskiy sovet = Medical Council. 2022; 16(14): 193–199 (In Russ.)]. https://doi.org/10.21518/2079- 701X-2022-16-14-193-199. EDN: RGSTAV.
  11. Белокриницкая Т.Е., Фролова Н.И., Мудров В.А. с соавт. Постковидный синдром у молодых здоровых женщин: миф или реальность? Гинекология. 2023; 25(3): 341–347. [Belokrinitskaya T.E., Frolova N.I., Mudrov V.A. et al. Post-COVID-19-syndrome in young healthy women: Myth or reality? Ginekologiya = Gynecology. 2023; 25(3): 341–347 (In Russ.)]. https://doi.org/10.26442/20795696.2023.3.202333. EDN: YKDIFS.
  12. Куприянова А.А., Шевцова В.И., Колпачева М.Г. Особенности течения постковидного синдрома у пациентов разных возрастных групп. Смоленский медицинский альманах. 2023; (4): 22–24. [Kupriyanova A.A., Shevtsova V.I., Kolpacheva M.G. Features of the course of postcovid syndrome in patients of different age groups. Smolenskiy meditsinskiy al’manakh = Smolensk Medical Almanac. 2023; (4): 22–24 (In Russ.)]. https://doi.org/10.37903/SMA.2023.4.7. EDN: GKASDT.
  13. Исаева А.В., Ветлужская М.В., Коробейникова А.Н., Власова А.В. Клинические фенотипы и особенности течения постковидного синдрома. Профилактическая медицина. 2023; 26(9): 66–73. [Isaeva A.V., Vetluzhskaya M.V., Korobeynikova A.N., Vlasova A.V. Clinical phenotypes and features of the post-COVID syndrome course. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2023; 26(9): 66–73 (In Russ.)]. https://doi.org/10.17116/profmed20232609166. EDN: ILJZJU.
  14. Карасева А.А., Афанасьева А.Д., Гарбузова Е.В. с соавт. Степени тяжести постковидного синдрома у реконвалесцентов COVID-19 и их ассоциации с основными факторами риска хронических неинфекционных заболеваний. Архивъ внутренней медицины. 2024; 14(4): 298–311. [Karaseva A.A., Afanaseva A.D., Garbuzova E.V. et al. Severity of Postcovid syndrome in convalescent Covid-19 and their association with the main risk factors for chronic non-communicable diseases. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2024; 14(4): 298–311 (In Russ.)].

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. Cases of COVID-19 in patients included in the study

Жүктеу (45KB)
Метадеректер
3. Fig. 2. Percentage distribution of major chronic diseases in patients included in the study

Жүктеу (103KB)
Метадеректер
4. Fig. 3. Prevalence of the most frequently reported complaints in the post-COVID period in patients included in the study

Жүктеу (63KB)
Метадеректер

© Bionika Media, 2024